709O Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study

• Autoři: LORUSSO D; XIANG Y; HASEGAWA K; SCAMBIA G; GÁLVEZ Leiva; ELIAS P Ramos; ACEVEDO A; BEDNAŘÍKOVÁ Markéta; GOMES A.J.P.D.S.; MEJIA F Contreras; REISS A; ZAGOURI F; LEE J-Y; SAEVETS V; AYHAN A; LIU P; YAMADA K U; PUGLISI M; PIGNATA S; DUSKA L
• Rok publikování: 2024
• Druh: Konferenční abstrakty